Peter Declercq

3.0k total citations
65 papers, 2.1k citations indexed

About

Peter Declercq is a scholar working on Molecular Biology, Clinical Biochemistry and Surgery. According to data from OpenAlex, Peter Declercq has authored 65 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 16 papers in Clinical Biochemistry and 14 papers in Surgery. Recurrent topics in Peter Declercq's work include Peroxisome Proliferator-Activated Receptors (20 papers), Metabolism and Genetic Disorders (15 papers) and Adipose Tissue and Metabolism (8 papers). Peter Declercq is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (20 papers), Metabolism and Genetic Disorders (15 papers) and Adipose Tissue and Metabolism (8 papers). Peter Declercq collaborates with scholars based in Belgium, United States and France. Peter Declercq's co-authors include Myriam Baes, Guy P. Mannaerts, Paul P. Van Veldhoven, G P Mannaerts, Ilse Vanhorebeek, Luc J. Debeer, Eveline Baumgart‐Vogt, Désiré Collen, Peter Carmeliet and Markus Grabenbauer and has published in prestigious journals such as The Lancet, Journal of Biological Chemistry and Nature Genetics.

In The Last Decade

Peter Declercq

60 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Declercq Belgium 25 1.5k 556 541 265 259 65 2.1k
Daisuke Kukidome Japan 21 1.1k 0.7× 287 0.5× 570 1.1× 349 1.3× 116 0.4× 30 2.2k
F. Umeda Japan 17 855 0.6× 434 0.8× 773 1.4× 273 1.0× 196 0.8× 55 2.5k
Minako Imamura Japan 20 1.2k 0.8× 395 0.7× 823 1.5× 460 1.7× 379 1.5× 41 2.8k
Naseem H. Ansari United States 26 1.0k 0.7× 280 0.5× 385 0.7× 141 0.5× 191 0.7× 67 2.0k
Merrie Mosedale United States 17 1.3k 0.9× 200 0.4× 1.1k 2.1× 412 1.6× 186 0.7× 30 2.5k
Will A. Coumans Netherlands 30 1.5k 1.0× 152 0.3× 692 1.3× 153 0.6× 191 0.7× 66 2.5k
Mark J. Holness United Kingdom 31 1.4k 0.9× 254 0.5× 1.1k 2.1× 277 1.0× 698 2.7× 77 2.8k
Mingzhan Xue United Kingdom 21 784 0.5× 969 1.7× 421 0.8× 132 0.5× 127 0.5× 39 1.9k
Tetsuji Etoh Japan 10 534 0.4× 372 0.7× 585 1.1× 230 0.9× 122 0.5× 34 1.7k
Antoni Paul United States 25 717 0.5× 246 0.4× 455 0.8× 702 2.6× 515 2.0× 48 2.5k

Countries citing papers authored by Peter Declercq

Since Specialization
Citations

This map shows the geographic impact of Peter Declercq's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Declercq with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Declercq more than expected).

Fields of papers citing papers by Peter Declercq

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Declercq. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Declercq. The network helps show where Peter Declercq may publish in the future.

Co-authorship network of co-authors of Peter Declercq

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Declercq. A scholar is included among the top collaborators of Peter Declercq based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Declercq. Peter Declercq is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gilissen, Liesbeth, Peter Declercq, Willy Peetermans, et al.. (2026). Clinical Outcome Associated With Beta‐Lactam Allergy Labels in Hospitalized Patients in Belgium. Clinical and Translational Allergy. 16(4). e70166–e70166.
2.
Gijsen, Matthias, Willy Peetermans, Eric Van Wijngaerden, et al.. (2024). Evaluation and implementation of optimized antimicrobial dosing strategies in obese and underweight patients. Infection. 52(6). 2297–2314.
3.
Declercq, Peter, Willem‐Jan Metsemakers, An Sermon, et al.. (2023). Bedside check of medication appropriateness (BED-CMA) as a risk-based tool for bedside clinical pharmacy services: A proof-of-concept study at the trauma surgery ward. Computational and Structural Biotechnology Journal. 22. 58–65.
4.
Declercq, Peter, et al.. (2022). From basic to advanced computerised intravenous to oral switch for paracetamol and antibiotics: an interrupted time series analysis. BMJ Open. 12(4). e053010–e053010. 4 indexed citations
5.
Declercq, Peter, Charalampos G. Zalavras, Ann Belmans, et al.. (2020). Impact of duration of perioperative antibiotic prophylaxis on development of fracture-related infection in open fractures. Archives of Orthopaedic and Trauma Surgery. 141(2). 235–243. 12 indexed citations
6.
Massa, Guy, et al.. (2018). Evaluation of the FreeStyle® Libre Flash Glucose Monitoring System in Children and Adolescents with Type 1 Diabetes. Hormone Research in Paediatrics. 89(3). 189–199. 48 indexed citations
7.
Declercq, Peter, et al.. (2015). Reduced length of stay in radical cystectomy patients with oral versus parenteral post-operative nutrition protocol. International Journal of Clinical Pharmacy. 37(2). 379–386. 11 indexed citations
8.
Declercq, Peter, et al.. (2015). Evaluation of parenteral nutrition use in patients undergoing major upper gastro-intestinal surgery. International Journal of Clinical Pharmacy. 37(4). 579–582. 1 indexed citations
9.
Jonge, Hylke de, Peter Declercq, Henriëtte de Loor, et al.. (2010). Apparent Elevation of Cyclosporine Whole Blood Concentrations in a Renal Allograft Recipient. Therapeutic Drug Monitoring. 32(5). 529–531. 7 indexed citations
10.
Vanhorebeek, Ilse, Arno Schad, Markus Grabenbauer, et al.. (2005). Absence of peroxisomes in mouse hepatocytes causes mitochondrial and ER abnormalities†. Hepatology. 41(4). 868–878. 142 indexed citations
11.
Baumgart‐Vogt, Eveline, Ilse Vanhorebeek, Markus Grabenbauer, et al.. (2001). Mitochondrial Alterations Caused by Defective Peroxisomal Biogenesis in a Mouse Model for Zellweger Syndrome (PEX5 Knockout Mouse). American Journal Of Pathology. 159(4). 1477–1494. 170 indexed citations
12.
Veldhoven, Paul P. Van, et al.. (2000). Do sphingoid bases interact with the peroxisome proliferator activated receptor α (PPAR-α)?. Cellular Signalling. 12(7). 475–479. 25 indexed citations
13.
Veldhoven, Paul P. Van, et al.. (1997). Metabolism of dolichol, dolichoic acid and nordolichoic acid in cultured cells. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 1347(1). 93–100. 12 indexed citations
14.
Baes, Myriam, Pierre Gressèns, Eveline Baumgart‐Vogt, et al.. (1997). A mouse model for Zellweger syndrome. Nature Genetics. 17(1). 49–57. 218 indexed citations
15.
Declercq, Peter, et al.. (1997). DNA Binding Preferences of PPARα/RXRα Heterodimers. Biochemical and Biophysical Research Communications. 233(1). 91–95. 20 indexed citations
16.
Stals, H, et al.. (1996). Palmitoyl‐CoA synthetase on the external surface of isolated rat hepatocytes. Cell Biochemistry and Function. 14(4). 277–281. 1 indexed citations
17.
Janssen, Ann, et al.. (1996). Sequence requirements for high affinity retinoid X receptor-α homodimer binding. Molecular and Cellular Endocrinology. 119(1). 11–20. 27 indexed citations
18.
Baes, Myriam, et al.. (1995). Antagonism of COUP-TF and PPARα-RXRα on the Activation of the Malic Enzyme Gene Promoter: Modulation by 9-cis-RA. Biochemical and Biophysical Research Communications. 215(1). 338–345. 25 indexed citations
19.
Stals, H, et al.. (1994). Regulation of triacylglycerol synthesis in permeabilized rat hepatocytes. FEBS Letters. 343(1). 99–102. 37 indexed citations
20.
Stals, H & Peter Declercq. (1992). A specific and inexpensive assay of radiolabeled long-chain acyl-coenzyme a in isolated hepatocytes. Analytical Biochemistry. 202(1). 117–119. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daisuke Kukidome Breakdown of academic impact, for papers by F. Umeda Breakdown of academic impact, for papers by Minako Imamura Breakdown of academic impact, for papers by Naseem H. Ansari Breakdown of academic impact, for papers by Merrie Mosedale Breakdown of academic impact, for papers by Will A. Coumans Breakdown of academic impact, for papers by Mark J. Holness Breakdown of academic impact, for papers by Mingzhan Xue Breakdown of academic impact, for papers by Tetsuji Etoh Breakdown of academic impact, for papers by Antoni Paul
Rankless by CCL
2026